Exogenous High-Mobility Group Box 1 Inhibits Apoptosis and Promotes the Proliferation of Lewis Cells via RAGE/TLR4-Dependent Signal Pathways
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exogenous High-Mobility Group Box 1 Inhibits Apoptosis and Promotes the Proliferation of Lewis Cells via RAGE/TLR4-Dependent Signal Pathways
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Volume 79, Issue 6, Pages 386-394
Publisher
Wiley
Online
2014-03-29
DOI
10.1111/sji.12174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGB1 induces an inflammatory response in endothelial cells via the RAGE-dependent endoplasmic reticulum stress pathway
- (2013) Ying Luo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of HIV protease, nucleoside/non-nucleoside reverse transcriptase inhibitors on Bax, Bcl-2 and apoptosis in two cervical cell lines
- (2013) Gbenga Anthony Adefolaju et al. BIOMEDICINE & PHARMACOTHERAPY
- The HMGB1–TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis
- (2013) Hua-Sheng Ding et al. GENE
- Unknown
- (2013) Daolin Tang et al. MOLECULAR MEDICINE
- The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics
- (2013) R Kang et al. ONCOGENE
- High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK
- (2013) Fu-ping Wang et al. PLoS One
- High-Mobility Group Boxes Mediate Cell Proliferation and Radiosensitivity via Retinoblastoma-Interaction-Dependent and -Independent Mechanisms
- (2012) Li-Li Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- RETRACTED: High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer
- (2012) Jie Chen et al. GYNECOLOGIC ONCOLOGY
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway
- (2012) Geum-Youn Gwak WORLD JOURNAL OF GASTROENTEROLOGY
- HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
- (2011) José Augusto Nogueira-Machado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CKD712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, inhibits the lipopolysaccharide-stimulated secretion of HMGB1 by inhibiting PI3K and classical protein kinase C
- (2011) Young Joo Oh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Intracellular HMGB1 Negatively Regulates Efferocytosis
- (2011) S. Banerjee et al. JOURNAL OF IMMUNOLOGY
- NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response
- (2011) Y Zhang et al. ONCOGENE
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
- (2010) D Tang et al. ONCOGENE
- C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells
- (2007) Ko-ichi Kawahara et al. CARDIOVASCULAR PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started